Inhibitory Effects of Curcumin on in Vitro Lipoxygenase and Cyclooxygenase Activities in Mouse Epidermis

Cancer Research

Volumn 51, Issue 3, 1991, Pages 813-819

  Abidi, Tanveer F ^c   Laskin, Jeffrey D ^c   Conney, Allan H ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CAFFEIC ACID; CURCUMIN; ENZYME INHIBITOR; FERULIC ACID; LIPOXYGENASE; PHORBOL ESTER; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION;

ANIMAL; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CAFFEIC ACIDS; CHLOROGENIC ACID; COUMARIC ACIDS; CURCUMIN; DERMATITIS, CONTACT; FEMALE; HYDROXYEICOSATETRAENOIC ACIDS; IN VITRO; LIPOXYGENASE; MICE; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE;

EID: 0026029402     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Chopra, R. N., Chopra, I. C., Manda, K. L., and Kapur, L. D. Indigenous Drugs of India, Ed. 2, pp. 325-327. Calcutta: Dhur, 1958.
2. Nadkarn, K. M. Curcuma longa. In: K. M. Nadkarni (ed.), India Materia Medica, pp. 414-416. Bombay: Popular Prakashan Publishing Co., 1976.
3. Wealth of India. In: Raw Materials, p. 402. New Delhi: CSIR, 1950.
4. Bacon, E. Health protection branch regulation of food additives. Can. Pharm. J., 112: 340-344, 1979.
5. Marmion, D. M. Colorants exempt from certification. In: Handbook of U. S. Colorants for Food, Drugs, and Cosmetics, pp. 86-87. New York: John Wiley & Sons, 1979.
6. Govindarajan, V. S. Tumeric chemistry, technology, and quality. Crit. Rev. Food Sci. Nutr., 12: 199-301, 1980.
7. Tonnesen, H. H. Chemistry, stability and analysis of curcumin, a naturally occurring drug molecule. Ph. D. dissertation. The Institute of Pharmacy, University of Oslo, 1986.
8. Schwarz, J. A., Viaje, A., and Slaga, T. J. Flucinolone acetonide: a potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem. Biol. Interact., 17: 331-347, 1977.
9. Slaga, T. J., and Scribner, J. D. Brief communication: inhibition of tumor initiation and promotion by anti-inflammatory agents. J. Natl. Cancer Inst., 51: 1723-1725, 1973.
10. Viaje, A., Slaga, T. J., Wigler, M., and Weinstein, I. B. Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, Phorbol ester-induced cellular proliferation, and production of plasminogen activator. Cancer Res., 37: 1530-1536, 1977.
11. Kozumbo, W. J., Seed, J. L., and Kensler, T. W. Inhibition by 2(3)-fert-butyl- 4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylPhorbol-13-acetate. Cancer Res., 43:2555-2559,1983.
12. Nakadate, T., Yamamoto, S., Aizu, E., and Kalo, R. Effects of flavonoids and antioxidants on 12-O-tetradecanoylPhorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipox ygenase inhibition by these compounds. Gann, 75: 214-222, 1984.
13. Smart, R. C., Huang, M-T., Han, Z. T., Kaplan, M. C., Focella, A., and Conney, A. H. Inhibition of 12-O-tetradecanoylPhorbol-13-acetate induction of ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate. Cancer Res., 47: 6633-6638, 1987.
14. Sharma, O. P. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol., 25: 1811-1812, 1976.
15. Toda, S., Miyase, T., Arichi, H., Tanizawa, H., and Takino, Y. Natural antioxidants. III. Antioxidative components isolated from rhizome of Cur cuma longa L. Chem. Pharm. Bull. (Tokyo), 33: 1725-1728, 1985.
16. Srimal, R. C., and Dhawan, B. N. Pharmacology of diferuloyl methane (curcumin), a nonsteroidal anti-inflammatory agent. J. Pharm. Pharmacol., 25:447-452, 1973.
17. Rao, T. S., Basu, N., and Siddiqui, H. H. Anti-inflammatory activity of curcumin analogues. Indian J. Med. Res., 75: 574-578, 1982.
18. Mukhopadhyay, A., Basu, N., Ghatak, N., and Gujral, P. K. Anti-inflam matory and irritant activities of curcumin analogues in rats. Agents Actions, 12: 508-515, 1982.
19. Yegnanarayan, R., Saraf, A. P., and Balwani, J. H. Comparison of antiinflammatory activity of various extracts of Curcuma longa (Linn). Indian J. Med. Res., 64:601-608, 1976.
20. Huang, M-T., Smart, R. C., Wong, C-Q., and Conney, A. H. Inhibitory effect of curcumin, chlorogenic acid, cafleic acid, and ferulic acid on tumor pro motion in mouse skin by 12-O-tetradecanoylPhorbol-13-acetate. Cancer Res., 48: 5941-5946, 1988.
21. Kato, R., Nakadate, T., Yamamoto, S., and Sugimura, T. Inhibition of 12- O-tetradecanoylPhorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis (Lond.), 4: 1301-1305, 1983.
22. Fischer, S. M., Baldwin, J. K., Jasheway, D. W., Patrick, K. E., and Cameron, G. S. Phorbol ester induction of 8-lipoxygenase in inbred SENCAR(SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction. Cancer Res., 48: 658-664, 1988.
23. Lysz, T. W., and Needleman, P. Evidence for two forms of fatty acid cyclooxygenase in brain. J. Neurochem., 38: 1111-1117, 1982.
24. Lysz, T. W., Centra, M., Markey, K., and Keeling, P. E. Evidence for increased activity of mouse brain fatty acid cyclooxygenase following druginduced convulsions. Brain Res., 408: 6-12, 1987.
25. Jeng, A. Y., Sharkey, N. A., and Blumberg, P. M. Purification of stable protein kinase C from mouse brain cytosol by specific ligand elution using fast protein liquid chromatography. Cancer Res., 46: 1966-1071, 1986.
26. Abidi, T. F., Faaland, C. A., Scala, D. D., Rhein, L. D., and Laskin, J. D. Ethoxylated alcohol (Neodol-12) and other surfactants in the assay of protein kinase C. Biochem. Biophys. Acta, 992: 362-368, 1989.
27. Hidata, H., Inagaki, M., Kawamoto, S., and Sasaki, Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry, 23: 5036-5041, 1984.
28. Sugiura, M., Naito, Y., Yamaura, Y., Fukaya, C., and Yokoyama, K. Inhib itory activities and inhibition specificities of caffeic acid derivatives and related compounds toward 5-lipoxygenase. Chem. Pharm. Bull. (Tokyo), 37: 1039-1043, 1989.
29. La Vecchia, C., Ferraron, M., Negri, E., D'Avanzo, B., Decarli, A., Levi, F., and Franceschi, S. Coffee consumption and digestive tract cancers. Cancer Res., 49: 1049-1051, 1989.
30. Nakadate, T., Yamamoto, S., Ishii, M., and Kalo, R. Inhibition of 12-OtetradecanoylPhorbol- 13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: possible role of product(s) of lipoxygenase pathway. Carcinogenesis (Lond.), 3: 1411-1414, 1982.
31. Fischer, S. M., Mills, G. D., and Slaga, T. J. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogen esis (Lond.), 3: 1243-1245, 1982.
32. Nakadate, T., Yamamoto, S., Ishii, M., and Kato, R. Inhibition of 12-OtetradecanoylPhorbol- 13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase 42 inhibitors and lipoxygenase inhibitor. Cancer Res., 42:2841-2845, 1982.
33. Furstenberger, G., Gross, M., and Marks, F. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis (Lond.), 10: 91-96, 1989.
34. Nakadate, T., Aziu, E., Yamamoto, S., and Kato, R. Some properties of lipoxygenase activities in cytosol and microsomal fractions of mouse epider mal homogenate. Prostaglandins Leukotrienes Med., 21: 305-319, 1986.
35. Gschwendt, M., Furstenberger, G., Kittstein, W., Besemfelder, E., Hull, W. E., Hagedorn, H., Opferkuch, H. J., and Marks, F. Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with Phorbol ester in vivo: identification by H-NMR and GC-MS spectroscopy. Carcinogenesis (Lond.), 7: 449-455, 1986.
36. Higgs, G. A., Salmon, J. A., and Spayne, J. A. The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin. Br. J. Pharmacol., 74: 429-433, 1981.
37. Camp, R. O. R. Prostaglandins, hydroxyfatty acids, leukotrienes, and inflam mation of the skin. Clin. Exp. Dermatol., 7: 435-444, 1982.
38. Chang, J., Carlson, R. P., O'Neill-Davis, L., Lamb, B., Sharma, R. N., and Lewis, A. J. Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis. Inflammation, 10:205-214, 1986.
39. Hamberg, M., and Samuelsson, B. Prostaglandin endoperoxides: novel trans formations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. USA, 71: 3400-3404, 1974.
40. Ammarsirani, S., Hamberg, M., Samuelsson, B., Duell, E. A., and Stawiski, M., and Voorhees, J. J. Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2a in epidermis of psoriasis. Proc. Natl. Acad. Sci. USA, 72: 5130-5134, 1975.
41. Gryglewski, R. J. Effects of ant ainflammatory steroids on arachidonate cascade. In: G. Weissman, B. Samuelsson, and R. Paoletti (eds.), Advances in Inflammation Research, Vol. 1, pp. 505-513. New York: Raven Press, 1979.
42. Fischer, S. M., and Adams, L. M. Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachi donic acid metabolism. Cancer Res., 45: 3130-3136, 1985.
43. Horiuchi, T., Fujiki, H., Hakii, H., Suganuma, M., Yamashita, K., and Sugimua, T. Modulation of Phorbol ester receptors in mouse skin by appli cation of quercetin. Gann, 77: 526-531, 1986.
44. Nakadate, T., Yamamoto, S., Iseki, H., Sonoda, S., Takemura, S., Ura, A., Hosoda, Y., and Kato, R. Inhibition of 12-O-tetradecanoylPhorbol-13-acetate- induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase 42 inhibitor. Gann, 73: 841-843, 1982.
45. Slaga, T. J. Multistage skin carcinogenesis: a useful model for the study of the chemoprevention of cancer. Acta Pharmacol. Toxicol., 55: 107-124, 1984.
46. Slaga, T. J., and Digiovanni, J. Inhibition of chemical carcinogenesis. In: C. E. Searle (ed.), Chemical Carcinogens, Ed. 2, Vol. 2, ACS Monograph 182, pp. 1279-1321. Washington, DC: American Chemical Society, 1984.
47. Inoue, H., Mori, T., and Koshihara, Y. Sulfidopeptide-leukotrienes are major mediators of arachidonic acid-induced mouse ear edema. Prostaglandins, 36: 731-739, 1988.
48. Nagabhushan, M., and Bhide, S. V. Nonmutagenicity of curcumin and its antimutagenic action versus chili and capsaicin. Nutr. Cancer, 8: 201-210, 1986.
49. Nagabhushan, M., Amonkar, A. J., and Bhide, S. V. In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem. Toxicol., 25: 545-547, 1987.
50. Kuttan, R., Bhanumathy, P., Ninnala, K., and George, M. C. Potential anticancer activity of tumeric (Curcuma longa). Cancer Lett., 29: 197-202, 1985.